TickerGuard
Buy Day today: Poor (44) Weak market breadth · today: Core PCE (August) ≈
RLAY

Relay Therapeutics Inc

Healthcare · Biotechnology

18.00$ -6.8% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow RLAY
Line item 2018 2019 2020 2021 2022 2023 2024 2025
– – – – – – – –
– +32.1% +24.7% +10.6% +5.2% +27.6% +3.7% -125.5%
– +54.3% +617.2% +51.6% +15.9% +53.2% +9.4% -33.7%
– -30.4% +1,463.9% +62.6% +9.5% – – –
– – -2,076.1% – -88.4% -388.6% – -259.4%
– +374.3% -75.9% +79.8% +161.1% -54.5% -51.1% -79.7%
– +18,889.5% – -687.1% -60.6% – -115.9% –
– – +7,552.8% -98.6% -71.3% – – -27.0%
– – – – – – – –
– -98.6% +7,508.1% -9.0% -25.3% -88.0% +677.4% -99.4%
– -208.7% – -140.9% – – – –
– – – – – – – –

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?